AI Science Tracker
EN

A CT-Based Clinical, Radiological and Radiomic Machine Learning Model for Predicting Malignancy of Solid Renal Tumors (UroCCR-75).

Department of Imaging and Interventional Radiology, Hôpital Pellegrin, Place Amélie-Raba-Léon, 33076 Bordeaux, France.; SOPHiA GENETICS, Multimodal Research, Cité de la Photonique-Bâtiment GIENAH, 11 Avenue de Canteranne, 33600 Pessac, France.; Department of Urology, Hôpital Pellegrin, Place Amélie-Raba-Léon, 33076 Bordeaux, France. · 31 Jul 2023 · medicine

Discovery

A CT-Based Clinical, Radiological and Radiomic Machine Learning Model for Predicting Malignancy of Solid Renal Tumors (UroCCR-75).

Source check: Source checked. Not independent scientific confirmation.

Finding: A CT radiomics model classified solid renal-tumor malignancy in a clinical cohort with reported cross-validation metrics. AI role: Clinical, radiomic and machine-learning classification models. The article appeared in Diagnostics (Basel, Switzerland).

Technology: Clinical, radiomic and machine-learning classification models

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
Clinical, radiomic and machine-learning classification models
Test and result
A CT radiomics model classified solid renal-tumor malignancy in a clinical cohort with reported cross-validation metrics.
Limitation / still unknown
The result is limited to the described dataset, cohort, experimental system, or validation design; generalization beyond that scope and downstream real-world benefit are not established. Author affiliation was not stated in the reviewed abstract or metadata.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC10417436/ · https://pubmed.ncbi.nlm.nih.gov/37568911/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.